Question to the Department of Health and Social Care:

To ask Her Majesty’s Government, further to the statement by Baroness Chisholm of Owlpen on 20 October (HL Deb, col 2484–90), whether the Pharmacy Integration Fund is still planned to rise to a total of £300 million by 2020–21, and whether the planned expenditure of £42 million over two years means that previously planned support is being cut back.

In 2016/17, it was planned that £20 million would be available for the Pharmacy Integration Fund (PhIF), rising by £20 million per year to a total of £100 million per year by 2020/21, so that over the course of 5 years, £300 million would be distributed through the Fund.

The establishment of the Fund and associated work programme for 2016/17 is dependent on the overall financial pressures for NHS England, set out in the Five Year Forward View, and the priorities identified through the recently published National Health Service planning guidance.

This means through the business planning process, funding of £42 million has now been secured for 2016/17 and 2017/18.

There will be further business planning within NHS England for 2018 onwards which will determine the future provision within the Fund. However, the PhIF is a key priority for NHS England and is aligned with the Five Year Forward View priorities.